Literature DB >> 15265335

High altitude cerebral edema.

Peter H Hackett1, Robert C Roach.   

Abstract

This review focuses on the epidemiology, clinical description, pathophysiology, treatment, and prevention of high altitude cerebral edema (HACE). HACE is an uncommon and sometimes fatal complication of traveling too high, too fast to high altitudes. HACE is distinguished by disturbances of consciousness that may progress to deep coma, psychiatric changes of varying degree, confusion, and ataxia of gait. It is most often a complication of acute mountain sickness or high altitude pulmonary edema. The current leading theory of its pathophysiology is that HACE is a vasogenic edema; that is, a disruption of the blood-brain barrier, and we review possible mechanisms to explain this. Treatment and prevention of HACE are similar to those for the other altitude illnesses, but with greater emphasis on descent and steroids. We conclude the review with several case histories to illustrate key clinical features of the disorder.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265335     DOI: 10.1089/1527029041352054

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  51 in total

1.  Distortion product otoacoustic emissions for assessment of intracranial hypertension at extreme altitude?

Authors:  Bernhard Olzowy; Gregor von Gleichenstein; Martin Canis; Klaus Mees
Journal:  Eur J Appl Physiol       Date:  2008-01-11       Impact factor: 3.078

Review 2.  Obstructive sleep apnea and cognitive impairment: addressing the blood-brain barrier.

Authors:  Diane C Lim; Allan I Pack
Journal:  Sleep Med Rev       Date:  2013-03-28       Impact factor: 11.609

3.  Overactivation of corticotropin-releasing factor receptor type 1 and aquaporin-4 by hypoxia induces cerebral edema.

Authors:  Shao-Jun Chen; Jia-Fang Yang; Fan-Ping Kong; Ji-Long Ren; Ke Hao; Min Li; Yuan Yuan; Xin-Can Chen; Ri-Sheng Yu; Jun-Fa Li; Gareth Leng; Xue-Qun Chen; Ji-Zeng Du
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-21       Impact factor: 11.205

4.  Biomarkers of hypoxia, endothelial and circulatory dysfunction among climbers in Nepal with AMS and HAPE: a prospective case-control study.

Authors:  Kevin R Barker; Andrea L Conroy; Michael Hawkes; Holly Murphy; Prativa Pandey; Kevin C Kain
Journal:  J Travel Med       Date:  2016-03-16       Impact factor: 8.490

5.  High-altitude cerebral oedema mimicking stroke.

Authors:  Uday Yanamandra; Amul Gupta; Sagarika Patyal; Prem Prakash Varma
Journal:  BMJ Case Rep       Date:  2014-03-26

Review 6.  Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.

Authors:  Víctor H Nieto Estrada; Daniel Molano Franco; Roger David Medina; Alejandro G Gonzalez Garay; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2017-06-27

7.  Basic medical advice for travelers to high altitudes.

Authors:  Kai Schommer; Peter Bärtsch
Journal:  Dtsch Arztebl Int       Date:  2011-12-09       Impact factor: 5.594

8.  A role for succinate dehydrogenase genes in low chemoresponsiveness to hypoxia?

Authors:  Jean-Paul Richalet; Anne-Paule Gimenez-Roqueplo; Séverine Peyrard; Annabelle Vénisse; Laure Marelle; Nelly Burnichon; Anissa Bouzamondo; Xavier Jeunemaitre; Michel Azizi; Jean-Luc Elghozi
Journal:  Clin Auton Res       Date:  2009-12       Impact factor: 4.435

Review 9.  Physiology and pathophysiology at high altitude: considerations for the anesthesiologist.

Authors:  Kay B Leissner; Feroze U Mahmood
Journal:  J Anesth       Date:  2009-11-18       Impact factor: 2.078

10.  Effects of acute hypoxia and hyperthermia on the permeability of the blood-brain barrier in adult rats.

Authors:  Sirajedin S Natah; Sathya Srinivasan; Quentin Pittman; Zonghang Zhao; Jeff F Dunn
Journal:  J Appl Physiol (1985)       Date:  2009-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.